Abstract:Background: Efficacy of conventional sequential chemotherapy paradigm for advanced gastric cancer (AGC) patients has largely plateaued. Dynamic molecular changes during and after sequential chemotherapy have not been fully delineated. We aimed to profile the molecular evolutionary process of AGC patients during sequential chemotherapy by next generation sequencing (NGS) of plasma circulating tumor DNA (ctDNA). Methods: A total of 30 chemo-naïve patients who were diagnosed with unresectable advanced or metastatic stomach adenocarcinoma were enrolled. All patients received sequential chemotherapy regimens following the clinical guideline. One hundred and eight serial peripheral blood samples were collected at baseline, radiographical assessment and disease progression. Plasma ctDNA was isolated and a customized NGS panel was used to detect the genomic features of ctDNA including single nucleotide variants (SNVs) and gene-level copy number variations (CNVs). KEGG pathway enrichment analysis was performed. Results: Platinum-based combination chemotherapy was administrated as first-line regimen. Objective response rate was 50% (15/30). Patients with higher baseline values of copy number instability (CNI), CNVs and variant allel frequency (VAF) were more sensitive to platinum-based first-line regimens. Tumor mutation burden (TMB), CNI and CNV burden at partial response and stable disease were significantly lower than those at baseline, where at progressive disease they recovered to baseline levels. Dynamic change of TMB (ΔTMB) was correlated with progression-free survival of first-line treatment. Fluctuating changes of SNVs and gene-level CNVs could be observed during sequential chemotherapy. Under the pressure of conventional chemotherapy, the number of novel gene-level CNVs were found to be higher than that of novel SNVs. Such novel molecular alterations could be enriched into multiple common oncologic signaling pathways, including EGFR tyrosine kinase inhibitor resistance and platinum drug resistance pathways, where their distributions were found to be highly heterogenous among patients. The impact of subsequent regimens, including paclitaxel-based and irinotecan-based regimens, on the molecular changes driven by first-line therapy was subtle. Conclusion: Baseline and dynamic changes of genomic features of ctDNA could be biomarkers for predicting response of platinum-based first-line chemotherapy in AGC patients. After treatment with standard chemotherapy regimens, convergent oncologic pathway enrichment was identified, which is yet characterized by inter-patient heterogenous gene-level CNVs.

Next-generation sequencing assistants in diagnosis of testicular metastatic adenocarcinoma after gastric cancer surgery

Clinical significance of multi-sample next-generation sequencing for detection of gene mutations in non-small cell lung cancer

Next-generation Sequencing Identifies the Mutational Signature of Double Primary and Metastatic Malignancies: A Case Report

Mutational landscape of gastric cancer and clinical application of genomic profiling based on target next-generation sequencing

Genomic Alterations in Advanced Gastric Cancer Endoscopic Biopsy Samples Using Targeted Next-Generation Sequencing

Appolication of next-generation sequencing for the screening of hereditary gastrointestinal cancer

Detection of genes related to peritoneal metastasis of primary gastric cancer based on large-panel Next Generation Sequencing.

Application of next-generation sequencing in the diagnosis of gastric cancer

Comprehensive Genetic Mutation Analysis of Human Gastric Adenocarcinomas.

Whole-genome sequencing of an advanced case of small-cell gallbladder neuroendocrine carcinoma

Genomic characterization of Chinese locally advanced or metastatic gastric cancer.

Characteristics and response to Next‐generation sequencing‐guided therapy in locally advanced or metastatic esophageal cancer

TP53 mutation and MET amplification in circulating tumor DNA analysis predict disease progression in patients with advanced gastric cancer

Molecular evolutionary process of advanced gastric cancer during sequential chemotherapy detected by circulating tumor DNA

Molecular characterization of gastric-type endocervical adenocarcinoma using next-generation sequencing

Next-generation sequencing-based detection in a breast MMPMN patient with EGFR T790M mutation: a rare case report and literature review

Diagnosis of lung squamous cell carcinoma based on metagenomic Next-Generation Sequencing

Next-Generation Sequencing Analysis of ctDNA for the Detection of Glioma and Metastatic Brain Tumors in Adults

Next-generation Sequencing Reveals Mutational Accordance Between Cell-Free DNA from Plasma, Malignant Pleural Effusion and Ascites and Directs Targeted Therapy in a Gastric Cancer Patient

Erratum: Whole Genome and Transcriptome Sequencing of Matched Primary and Peritoneal Metastatic Gastric Carcinoma

Whole-genome Sequencing Reveals the Mutational Landscape of Metastatic Small-Cell Gallbladder Neuroendocrine Carcinoma (GB-SCNEC).